rs2227580

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001145031.3(PLAU):​c.-294G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0086 in 1,613,832 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0076 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0087 ( 123 hom. )

Consequence

PLAU
NM_001145031.3 5_prime_UTR_premature_start_codon_gain

Scores

1
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.995

Publications

13 publications found
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038291514).
BP6
Variant 10-73911598-G-T is Benign according to our data. Variant chr10-73911598-G-T is described in ClinVar as Benign. ClinVar VariationId is 300740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00765 (1165/152338) while in subpopulation SAS AF = 0.0236 (114/4828). AF 95% confidence interval is 0.0201. There are 16 homozygotes in GnomAd4. There are 551 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1165 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145031.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLAU
NM_002658.6
MANE Select
c.43G>Tp.Val15Leu
missense
Exon 2 of 11NP_002649.2P00749-1
PLAU
NM_001145031.3
c.-294G>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 10NP_001138503.2P00749-2
PLAU
NM_001319191.2
c.-188G>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 10NP_001306120.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLAU
ENST00000372764.4
TSL:1 MANE Select
c.43G>Tp.Val15Leu
missense
Exon 2 of 11ENSP00000361850.3P00749-1
C10orf55
ENST00000409178.5
TSL:1
n.884C>A
non_coding_transcript_exon
Exon 5 of 5
PLAU
ENST00000446342.5
TSL:2
c.-294G>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 10ENSP00000388474.1P00749-2

Frequencies

GnomAD3 genomes
AF:
0.00768
AC:
1169
AN:
152220
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00186
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00615
Gnomad ASJ
AF:
0.0181
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0238
Gnomad FIN
AF:
0.00471
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0107
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0105
AC:
2609
AN:
249498
AF XY:
0.0120
show subpopulations
Gnomad AFR exome
AF:
0.00130
Gnomad AMR exome
AF:
0.00678
Gnomad ASJ exome
AF:
0.0185
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00535
Gnomad NFE exome
AF:
0.0105
Gnomad OTH exome
AF:
0.0121
GnomAD4 exome
AF:
0.00870
AC:
12712
AN:
1461494
Hom.:
123
Cov.:
32
AF XY:
0.00968
AC XY:
7035
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.00188
AC:
63
AN:
33478
American (AMR)
AF:
0.00669
AC:
299
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0185
AC:
483
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0281
AC:
2420
AN:
86204
European-Finnish (FIN)
AF:
0.00675
AC:
359
AN:
53148
Middle Eastern (MID)
AF:
0.0501
AC:
289
AN:
5768
European-Non Finnish (NFE)
AF:
0.00735
AC:
8168
AN:
1111964
Other (OTH)
AF:
0.0104
AC:
631
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
816
1632
2448
3264
4080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00765
AC:
1165
AN:
152338
Hom.:
16
Cov.:
32
AF XY:
0.00740
AC XY:
551
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00185
AC:
77
AN:
41572
American (AMR)
AF:
0.00608
AC:
93
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0181
AC:
63
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.0236
AC:
114
AN:
4828
European-Finnish (FIN)
AF:
0.00471
AC:
50
AN:
10620
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0107
AC:
725
AN:
68032
Other (OTH)
AF:
0.0123
AC:
26
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00943
Hom.:
39
Bravo
AF:
0.00659
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.0115
AC:
99
ExAC
AF:
0.0110
AC:
1339
Asia WGS
AF:
0.0100
AC:
37
AN:
3478
EpiCase
AF:
0.0123
EpiControl
AF:
0.0122

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
Quebec platelet disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
15
DANN
Benign
0.90
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.49
T
MetaRNN
Benign
0.0038
T
MetaSVM
Benign
-0.85
T
PhyloP100
0.99
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.10
Sift
Benign
0.32
T
Sift4G
Pathogenic
0.0
D
Vest4
0.051
MutPred
0.12
Loss of sheet (P = 0.0181)
MPC
0.28
ClinPred
0.0095
T
GERP RS
2.8
PromoterAI
-0.041
Neutral
gMVP
0.51
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227580; hg19: chr10-75671356; COSMIC: COSV65641865; COSMIC: COSV65641865; API